Adcharee Kongruang
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients.
Journal: Practical laboratory medicine
Published: March 28, 2024
Committed change of real-time quantitative PCR to droplet digital PCR for monitoring BCR::ABL1 transcripts in tyrosine kinase inhibitor treated CML.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 11, 2023
A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia.
Journal: Journal of mass spectrometry and advances in the clinical lab
Published: August 24, 2022
High Expression of miR-483-5p Predicts Chemotherapy Resistance in Epithelial Ovarian Cancer.
Journal: MicroRNA (Shariqah, United Arab Emirates)
Published: November 12, 2020
MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
Journal: MicroRNA (Shariqah, United Arab Emirates)
Published: February 10, 2020
Practical Laboratory Tools for Monitoring of BCR-ABL1 Transcripts and Tyrosine Kinase (TK) Domain Mutations in Chronic Myeloid Leukemia Patients Undergoing TK Inhibitor Therapy: A Single-Center Experience in Thailand.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: February 07, 2020
EGFL7 and RASSF1 promoter hypermethylation in epithelial ovarian cancer.
Journal: Cancer genetics
Published: October 16, 2017
Characterization and Prognosis Significance of JAK2 (V617F), MPL, and CALR Mutations in Philadelphia-Negative Myeloproliferative Neoplasms
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: November 29, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026